Inborn error of metabolism (Niemann-Pick disease type C, 3beta-hydroxy-delta5-C27-steroid dehydrogenase/isomerase (3beta-HSD) defficiency, lysosomal storage disorder, etc), hepatobiliary diaseses (steatosis, NAFLD, NASH, ALD, hepatitis B, hepatitis C, primary biliary cirrhosis, cholangitis, hepatic carcinoma)
Conditions
Interventions
None listed
Sponsors
Department of Pharmaceutical Sciences, Tohoku university hospital
Division of hepatology, Tohoku university hospital, Division of pediatrics, Tohoku university hospital, Junshin clinic, bile acid institute, Sanin rosai hospital, Department of child neurology, Tottori university, Division of pediatrics, Kumamoto university, Department of Neurology, Jichi medical university, Saitama medical center, Dokkyo university school of medicine, Advanced clinical research center, Institute of neurological disorders, Jichi Medical University Kanagawa Chil
s Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patient of inborn error of metabolism (Niemann-Pick disease type C, 3beta-hydroxy-delta5-C27-steroid dehydrogenase/isomerase (3beta-HSD) defficiency, lysosomal storage disorder, etc), and hepatobiliary diaseses (steatosis, NAFLD, NASH, ALD, hepatitis B, hepatitis C, primary biliary cirrhosis, cholangitis, hepatic carcinoma).
Exclusion criteria
Exclusion criteria: No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| m/z and peak intensity of cholesterol metebolites | — |
Countries
Japan
Contacts
Public ContactMasamitsu Maekawa
Tohoku university hospital Department of pharmaceutical sciences
Outcome results
None listed